Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Oncology

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    February 2023
  1. DOGAN I, Kizildag I, Ozkurt S, Ibis K, et al
    Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process.
    Oncology. 2023 Feb 21:1-8. doi: 10.1159/000529030.
    PubMed     Abstract available


    September 2022
  2. SAWA A, Bando H, Kamohara R, Takeuchi N, et al
    Absolute lymphocyte count (ALC) as an independent prognostic factor in metastatic breast cancer: a retrospective study.
    Oncology. 2022 Sep 13. pii: 000526963. doi: 10.1159/000526963.
    PubMed     Abstract available


    August 2022
  3. JAFRI M, Kristeleit H, Misra V, Baxter M, et al
    Eribulin treatment for patients with metastatic breast cancer: The United Kingdom experience - a multicenter retrospective study.
    Oncology. 2022 Aug 31. pii: 000526140. doi: 10.1159/000526140.
    PubMed     Abstract available


    July 2022
  4. CHOI HJ, Lee JH, Jung CS, Lee JE, et al
    Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Oncology. 2022 Jul 26. pii: 000526155. doi: 10.1159/000526155.
    PubMed     Abstract available


    April 2022
  5. NGUYEN V, Chen J, Lord R, Preda V, et al
    The Impact of Multidisciplinary Weight Management on Body Weight and Body Mass Composition in Women with Breast Cancer Post-Adjuvant Chemotherapy: A Retrospective Chart Review.
    Oncology. 2022 Apr 11. pii: 000524519. doi: 10.1159/000524519.
    PubMed     Abstract available


    March 2022
  6. SHIKDAR S, Hall S, Taylor B, de Los Angeles J, et al
    Evaluating the Response of Palbociclib on Progression Free Survival in Hormone Receptor Positive Metastatic Breast Cancer.
    Oncology. 2022 Mar 28. pii: 000524340. doi: 10.1159/000524340.
    PubMed     Abstract available


  7. CHAUHAN D, Geetika, Kumar S, Kumar R, et al
    Combined Interaction of Cellular and Extracellular Components Causes Genetic Cascade Activation in Breast Cancer Metastasis.
    Oncology. 2022 Mar 25. pii: 000524302. doi: 10.1159/000524302.
    PubMed     Abstract available


    February 2022
  8. FUJITA N, Fujita K, Kim SJ, Iguchi C, et al
    Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-up of Prognostic Study Using Propensity Score Matching.
    Oncology. 2022 Feb 3. pii: 000522384. doi: 10.1159/000522384.
    PubMed     Abstract available


    January 2022
  9. BILGILIER C, Fureder T, Kastner MT, Vass Z, et al
    Oral Abundance of Actinomyces spp. in Breast Cancer Patients.
    Oncology. 2022 Jan 20. pii: 000522070. doi: 10.1159/000522070.
    PubMed     Abstract available


    December 2021
  10. FABI A, Ciccarese M, Scagnoli S, Russillo M, et al
    Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
    Oncology. 2021 Dec 7. pii: 000521252. doi: 10.1159/000521252.
    PubMed     Abstract available


  11. YAMAGUCHI K, Matsunuma R, Hayami R, Tsuneizumi M, et al
    Comparison of the Modified IHC4 Score and 21-Gene Recurrence Score Assay in Patients with Estrogen Receptor-Positive Breast Cancer.
    Oncology. 2021 Dec 7. pii: 000521287. doi: 10.1159/000521287.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: